Inflammatory Process in Type 2 Diabetes
- 28 November 2006
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1084 (1), 89-117
- https://doi.org/10.1196/annals.1372.039
Abstract
Abstract: Population‐based studies have shown strong relationship between inflammatory markers and metabolic disturbances, obesity, and atherosclerosis, whereas inflammation has been considered as a “common soil” between these clinical entities and type 2 diabetes (T2D). The accumulation of macrophages in adipose tissue (AT), the common origin of macrophages and adipocytes, the prevalent presence of peripheral mononuclear cells, and apoptotic β cells by themselves seem to be the sources of inflammation present in T2D, since they generate the mediators of the inflammatory processes, namely cytokines. The main cytokines involved in the pathogenesis of T2D are interleukin‐1β (IL‐1β), with an action similar to the one present in type 1 diabetes, tumor necrosis factor‐α (TNF‐α), and IL‐6, considered as the main regulators of inflammation, leptin, more recently introduced, and several others, such as monocyte chemoattractant protein‐1, resistin, adiponectin, with either deleterious or beneficial effects in diabetic pathogenesis. The characterization of these molecules targeted diabetes treatment beyond the classical interventions with lifestyle changes and pharmaceutical agents, and toward the determination of specific molecular pathways that lead to low grade chronic inflammatory state mainly due to an immune system's unbalance.This publication has 273 references indexed in Scilit:
- Inflammatory Markers and the Metabolic SyndromeJournal of the American College of Cardiology, 2005
- An immune origin of type 2 diabetes?Diabetologia, 2005
- Effect of a Mediterranean-Style Diet on Endothelial Dysfunction and Markers of Vascular Inflammation in the Metabolic SyndromeJAMA, 2004
- IL-6 protects pancreatic islet beta cells from pro-inflammatory cytokines-induced cell death and functional impairment in vitro and in vivoTransplant Immunology, 2004
- Fatty acids potentiate interleukin-1β toxicity in the β-cell line INS-1EBiochemical and Biophysical Research Communications, 2002
- Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitroExperimental & Molecular Medicine, 2001
- Acute-Phase Proteins and Other Systemic Responses to InflammationNew England Journal of Medicine, 1999
- T lymphopenia in obese diabetic (dbdb) mice is non-selective and thymus independentLife Sciences, 1998
- Leptin Induces Proliferation of Pancreatic β Cell Line MIN6 through Activation of Mitogen-Activated Protein KinaseBiochemical and Biophysical Research Communications, 1997
- Interleukin-6 Enhances Glucose Transport in 3T3-L1 AdipocytesBiochemical and Biophysical Research Communications, 1996